Recently published Immune Thrombocytopenia Market Insights report includes a comprehensive understanding of current treatment ...

An oral medication already approved for thrombocytopenia in patients with liver disease significantly improved platelet ...

The immune thrombocytopenia market is experiencing steady growth driven by increasing disease awareness and improved diagnosis rates. Advancements in targeted therapies, including thrombopoietin ...

UK MHRA grants marketing authorization to Sanofi’s rilzabrutinib to treat adults with immune thrombocytopenia when prior treatments have been insufficient: United Kingdom Monday ...

Researchers sought to determine whether carica papaya leaf extract would improve platelet recovery in patients with chemotherapy-induced thrombocytopenia.

Lead asset CAD-1005 being researched for prevention of life-threatening blood clots in patients with Heparin-induced Thrombocytopenia (HIT), ...

China NMPA accepts InnoCare’s NDA for BTK inhibitor, orelabrutinib to treat primary immune thrombocytopenia: Beijing Monday, June 1, 2026, 17:00 Hrs [IST] InnoCare Pharma, a lea ...

The prize is an oral spleen tyrosine kinase (SYK) inhibitor, called cevidoplenib, which has been developed by Korea’s Oscotec ...

Mandy Moore—mom to kids August, 5, Oscar, 3, and Louise, 21 months, with husband Taylor Goldsmith—shared her experience with ...

CHICAGO -- A randomized trial testing the addition of selinexor (Xpovio) to ruxolitinib (Jakafi) for myelofibrosis only met one of its two primary endpoints, yet the combination also showed a ...

Former teen-pop star Mandy Moore spent thousands of dollars trying to have a third child through IVF—only for the universe to ...

The A Walk to Remember actress—who shares kids August, 5, Oscar, 3, and Louise, 21 months, with husband Taylor Goldsmith—detailed her experience with the fertility treatment before welcoming her third ...